...
首页> 外文期刊>European Heart Journal: The Journal of the European Society of Cardiology >Relationship between discharge heart rate and mortality in patients after acute myocardial infarction treated with primary percutaneous coronary intervention.
【24h】

Relationship between discharge heart rate and mortality in patients after acute myocardial infarction treated with primary percutaneous coronary intervention.

机译:原发性经皮冠状动脉介入治疗对急性心肌梗死患者出院心率与死亡率的关系。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

AIMS: In patients with coronary artery disease, the prognostic value of heart rate has been mainly evaluated in patients with left ventricular dysfunction. Patients with ST-segment elevation acute myocardial infarction (STEMI) are currently treated with primary percutaneous coronary intervention (PCI) and in this contemporary population of patients, the relationship between heart rate and mortality during a follow-up >1 year has not been investigated. METHODS AND RESULTS: The population comprised 1453 STEMI patients treated with primary PCI. Resting heart rate was measured before discharge and all patients were followed prospectively. Main outcome measure: the endpoints were defined as all-cause mortality and cardiovascular mortality. The median follow-up duration was 40 months. During this period, 83(6%) patients died of which 52(4%) died from cardiovascular disease. After adjusting for parameters reflecting a greater infarct size and the presence of heart failure, heart rate at discharge remained a strong predictor of mortality. Patients with a heart rate of >/=70 b.p.m. had a two times increased risk of cardiovascular mortality at 1- and 4-year follow-up compared with patients with a heart rate <70 b.p.m.. In addition, every increase of 5 b.p.m. in heart rate at discharge was associated with a 29 and 24% increased risk of cardiovascular mortality at 1- and 4-year follow-up, respectively. CONCLUSION: In STEMI patients treated with primary PCI and optimal medical therapy, heart rate at discharge was an important predictor of mortality up to 4 years follow-up even after adjustment for parameters reflecting a greater infarct size and the presence of heart failure.
机译:目的:在冠心病患者中,心率的预后价值主要用于左心功能不全的患者。 ST段抬高的急性心肌梗死(STEMI)患者目前正在接受原发性经皮冠状动脉介入治疗(PCI),并且在这一当代患者群体中,未调查1年以上随访期间心率与死亡率之间的关系。 。方法和结果:人群包括1453例接受原发性PCI治疗的STEMI患者。出院前测量静息心率,并对所有患者进行前瞻性随访。主要结局指标:终点定义为全因死亡率和心血管疾病死亡率。中位随访时间为40个月。在此期间,有83(6%)名患者死亡,其中52(4%)名患者死于心血管疾病。调整参数以反映更大的梗塞面积和心力衰竭的存在后,出院时的心率仍然是死亡率的重要指标。心率> / = 70 b.p.m.与心率<70 b.p.m.的患者相比,在1年和4年随访中,心血管死亡的风险增加了两倍。此外,每增加5b.p.m。出院时心率的降低分别与1年和4年随访时心血管死亡风险增加29%和24%有关。结论:在接受原发性PCI和最佳药物治疗的STEMI患者中,即使调整了反映更大的梗死面积和出现心力衰竭的参数,出院时的心率仍是随访4年内死亡率的重要预测指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号